3D diffusion-weighted whole-body MR shows metastatic disease
Developed by radiologist Dr. Taro Takahara and colleagues at Tokai University School of Medicine in Japan, diffusion-weighted whole-body MR imaging with background body signal suppression (DWIBS) paves the way for practical whole-body 3D MR diffusion imaging. A new STIR-EPI sequence, performed with SENSE parallel processing, permits long acquisition times during free breathing to boost contrast resolution and overcome fat saturation problems.
Developed by radiologist Dr. Taro Takahara and colleagues at Tokai University School of Medicine in Japan, diffusion-weighted whole-body MR imaging with background body signal suppression (DWIBS) paves the way for practical whole-body 3D MR diffusion imaging. A new STIR-EPI sequence, performed with SENSE parallel processing, permits long acquisition times during free breathing to boost contrast resolution and overcome fat saturation problems.
Gray scale was reversed, black for white, producing a rotating 3D maximum intensity projection that resembled volumetric displays now generated with FDG-PET. The mechanism for producing DWI contrast in metastatic disease is not clearly understood but is thought to be associated with large cell sizes and high cellular densities that are common in cancerous tissue. Takahara described the approach at the International Society for Magnetic Resonance in Medicine meeting.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
